Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD), Regional Outlook– Global Forecast up

Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD), Regional Outlook– Global Forecast up to 2030


We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary methods for qualitative market assessments and market segmentation are top-down and bottom-up techniques. We take pride in our ability to use data triangulation to examine the market from three key angles: primary data mining, a specific statistical model and framework, and primary source data validation.

We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.

We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.

To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.

Electronic Drug Delivery Systems Market based on Type:
  • Electronic Wearable Infusion Pumps
  • Electronic Autoinjectors
  • Electronic Injection Pens
  • Electronic Inhalers
Electronic Drug Delivery Systems Market based on Indication:
  • Diabetes
  • Multiple Sclerosis
  • Cardiovascular Disease
  • Asthma & COPD
  • Other Indications
Electronic Drug Delivery Systems Market based on Geography:
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
The market for electronic drug delivery systems worldwide is examined, and as previously mentioned, market size, trends, and insights are given by nation, type, component, connectivity, system type, application, and end user.

The United States, Canada, Mexico, Germany, Italy, United Kingdom, France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa are the nations covered in the global electronic drug delivery systems market report.

In terms of market share and revenue, North America leads the global market for electronic drug delivery systems, and this trend is expected to continue throughout the forecast period of 2023–2030. This is the result of a widespread increase in electronic infusion pumps. In contrast, Asia-Pacific is anticipated to increase at the fastest rate over the course of the projection period due to the rising prevalence of heart disease and asthma brought on by the expansion of the pharmaceutical sector.

The report's nation section additionally includes specific market-impacting variables and domestic regulatory changes that have an effect on the market's present and future tendencies. The market scenario for each country is predicted using a variety of data points, including case studies, technical trends, porter's five forces analysis, and upstream and downstream value chain analysis. While providing a forecast analysis of the country data, other factors taken into account are the availability and presence of global brands, the difficulties these brands experience as a result of intense or little competition from local and domestic brands, the impact of domestic tariffs, and trade routes.

In-depth market analyses for each country's growth in healthcare capital equipment expenditures, installed bases of various product types for the global electronic drug delivery systems market, the impact of technology using life line curves and adjustments to healthcare regulatory scenarios, and their effects on the global electronic drug delivery systems market are all provided by the global electronic drug delivery systems market. The historical era of 2015–2020 is covered by the data.

Details per competitor are provided by the competitive landscape of the worldwide electronic drug delivery systems market. The company's overview, financials, revenue, market potential, R&D investment, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are all included in the details. The aforementioned data points only pertain to the companies' focus on the worldwide market for electronic medicine delivery systems.
  • This report illustrates the most vital attributes of the Electronic Drug Delivery Systems Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Electronic Drug Delivery Systems Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Electronic Drug Delivery Systems Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Electronic Drug Delivery Systems Market.


1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Type: Market Size & Analysis
5.1. Overview
5.2. Electronic Wearable Infusion Pumps
5.3. Electronic Autoinjectors
5.4. Electronic Injection Pens
5.5. Electronic Inhalers
6. Indication: Market Size & Analysis
6.1. Overview
6.2. Diabetes
6.3. Multiple Sclerosis
6.4. Cardiovascular Disease
6.5. Asthma & COPD
6.6. Other Indications
7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. MEDTRONIC PLC (IRELAND)
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. NOVO NORDISK (DENMARK)
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. INSULET CORPORATION (US)
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. BAYER AG (GERMANY)
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. UNITED THERAPEUTICS CORPORATION (US)
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. ASTRAZENECA (UK)
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. TANDEM DIABETES CARE (US)
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. MERCK GROUP (GERMANY)
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. AMGEN (US)
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. COMPANION MEDICAL (US)
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings